Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first effects of Wegovy within a few days to two weeks of their opening dose, though meaningful weight loss typically builds over months, not days. Semaglutide starts working on appetite and gut motility almost immediately after the first injection, but the body needs time to respond to progressively higher doses before that translates into the weight change you can see on the scales. These are prescription-only medicines, and a prescriber determines whether semaglutide is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception about Wegovy is that a slow start means the medicine is failing you. People see dramatic results in peer testimonials and assume they should feel the difference within days of the first injection. The reality is more nuanced, and more reassuring once you understand it.
Semaglutide's starting dose of 0.25 mg exists purely to let your body adjust. It is not intended to produce weight loss at that level. At this stage, many people notice a quieter appetite or feel full after less food, but the scales may not shift yet. That is by design, not by failure. The titration schedule (moving roughly every four weeks to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally the 2.4 mg maintenance dose) is what the prescriber is working towards. Each step allows your body to tolerate the medicine better and lets the dose do progressively more. Rushing it would increase the likelihood of side effects without speeding up results. Some people do lose weight in the early weeks; others see little change until they reach a higher dose. Both experiences are within normal range, as the NHS semaglutide medicines page reflects.
The practical upshot: measure progress monthly, not weekly, in the titration phase. Pick one morning, same conditions (before breakfast, after using the bathroom) and note the number. That single habit, done consistently, gives you a clearer picture than daily weigh-ins, which swing with hydration and meals.
The first physical sign most people report is altered appetite: food that used to feel compelling becomes easier to leave. If you are wondering how long until you feel effects of Wegovy, nausea is itself a sign the medicine is active, though it settles for most people within days to a couple of weeks as the body adapts. Reduced appetite often appears before weight loss does, because the calorie deficit takes time to translate into measurable fat loss.
Weight change becomes more consistent from around weeks four to eight for many people, especially as doses increase. By the time a person reaches and sustains the 2.4 mg maintenance dose, the trajectory becomes clearer. The landmark STEP 1 trial, published in the New England Journal of Medicine, followed adults over 68 weeks: at 2.4 mg, average weight reduction was approximately 15%, compared with about 2.4% on placebo. That is the benchmark the evidence supports, achieved over more than a year of sustained treatment, not a sprint to results.
The newer 7.2 mg dose, approved by the MHRA in early 2026 for adults with a BMI of 30 or above, showed around 20.7% average weight loss over 72 weeks in trials, bringing it closer to the results seen with tirzepatide. If you want to explore how Wegovy fits into the wider treatment picture, our weight-loss treatment overview lays out the options clearly.
A few factors genuinely affect how quickly Wegovy takes effect for any given person. Starting weight matters: people with higher BMIs sometimes see faster absolute loss early on, even if the percentage change takes time. Lifestyle factors alongside the medicine (eating patterns, protein intake, activity levels) influence how efficiently the calorie deficit converts into weight change. The medicine reduces appetite; it does not cancel out diet entirely.
Gastrointestinal side effects can occasionally slow things down indirectly. If nausea leads someone to eat very little or to skip meals erratically, the body's response becomes harder to read. Most GI effects are mild to moderate and transient, but it is worth flagging anything persistent to your prescriber or the aftercare team. Side effects and results are different signals; having one does not predict the other. For a detailed look at how long before Wegovy takes effect and what to expect physically in the early weeks, our page on how long Wegovy takes to work goes into that timeline more granularly.
Dose increases that are delayed (because of side effects or a missed injection) push the maintenance phase further out and, with it, the point at which you experience the medicine's full effect. A prescriber reviews this with you; it is not something to self-manage by adjusting the schedule. You can read more about the clinical process on our Wegovy treatment page.
NICE guidance on semaglutide (TA875) recommends that if less than 5% of body weight has been lost after six months at the maintenance dose, continuing treatment should be reviewed. This is a useful clinical anchor. It does not mean Wegovy has failed at month two or three, those months are often still in the titration phase. Questions about how long for Wegovy to take effect are very common at this stage, and understanding that the six-month clock tends to start once you are established on your maintenance dose, not from the first injection, can ease a lot of that uncertainty.
For most people who respond well to semaglutide, consistent progress is visible well before that checkpoint, and our guide on how long until Wegovy works gives a fuller picture of what to expect at each stage of treatment. Our clinical team, led by a GPhC-registered Independent Prescriber, reviews every repeat before it is dispensed, in part to make sure the treatment is doing what it should. If you have questions between orders, our aftercare team is available seven days a week via the contact page.
Starting treatment is a clinical decision made with a prescriber. If you would like to find out whether Wegovy is right for you, start your free consultation and a prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.